FDA-Approved Synthetic THC Reduces Nightmares In PTSD Patients, Study Finds
Dronabinol, a synthetic THC medication, has shown promising results in reducing the intensity of nightmares among people with post-traumatic stress disorder (PTSD), according to a new study—potentially alleviating one of the condition's most intrusive hallmarks.Findings published this week in the journal Nature Medicine by a group of German researchers show that dronabinol, the synthetic THC-based drug approved by the U.S. Food and Drug Administration, has a positive effect on sleep in PTSD pati...
Filters & Sorting